Maria Sharapova appeals 2-year doping ban

Maria Sharapova has appealed her two-year doping ban to the highest court in sports, seeking a ruling ahead of the Olympics in Rio de Janeiro.

Russian tennis star tested positive for meldonium in January

Russian tennis player Maria Sharapova has appealed her two-year doping ban to the Court of Arbitration for Sport. (Kenzo Tribouillard/Getty Images)

Maria Sharapova appealed her two-year doping ban to the highest court in sports on Tuesday, with an expedited ruling to be issued next month ahead of the Olympics in Rio de Janeiro.

Sharapova filed an appeal to the Court of Arbitration for Sport seeking to overturn or reduce the suspension imposed by the International Tennis Federation last week after the Russian tested positive for meldonium at the Australian Open in January.

CAS said both sides agreed to an "expedited procedure" which will allow the court to issue its ruling by July 18, at the latest.

The timing means that, if the suspension is thrown out, Sharapova would be eligible to compete at the Rio Games, which open on Aug. 5.

CAS said it hasn't decided whether to hold a hearing or not. The World Anti-Doping Agency said Tuesday that, after reviewing the original ruling, it would not file an appeal to CAS. WADA could have petitioned for either a harsher or more lenient punishment.

'Significant fault' 

Sharapova, a five-time Grand Slam champion, announced she would appeal following last Tuesday's announcement of her suspension.

An independent three-person panel appointed by the ITF said Sharapova did not intend to cheat because she didn't know meldonium was banned, but that she bore "sole responsibility" and "very significant fault" for the positive test.

Sharapova was provisionally suspended by the ITF in early March, when she announced at a news conference in Los Angeles that she failed a doping test in January.

Sharapova said then she was not aware that the World Anti-Doping Agency barred athletes from using meldonium, also known as mildronate, from January 1.

In addition to testing positive at the Australian Open, the ITF said she also failed a test for meldonium in an out-of-competition control in Moscow on Feb. 2.

Sharapova's ban is due to end on Jan. 25, 2018.

Sharapova said she first was prescribed the Latvian-made drug, typically used for heart conditions, for medical reasons in 2006. She could have been barred from competing for up to four years.


To encourage thoughtful and respectful conversations, first and last names will appear with each submission to CBC/Radio-Canada's online communities (except in children and youth-oriented communities). Pseudonyms will no longer be permitted.

By submitting a comment, you accept that CBC has the right to reproduce and publish that comment in whole or in part, in any manner CBC chooses. Please note that CBC does not endorse the opinions expressed in comments. Comments on this story are moderated according to our Submission Guidelines. Comments are welcome while open. We reserve the right to close comments at any time.